Nozilet Adult Nasal Solution contains Oxymetazoline 0.05% w/v, a topical nasal decongestant indicated for the temporary relief of nasal congestion associated with common cold, hay fever, sinusitis, and allergic rhinitis. Oxymetazoline acts as an alpha-adrenergic agonist, producing vasoconstriction of the nasal mucosal blood vessels, thereby reducing swelling and congestion. This action facilitates improved nasal airflow and eases breathing. Nozilet is intended for intranasal administration in adults and should be used according to the recommended dosage to avoid potential adverse effects. The onset of action is rapid, typically within minutes, providing prompt symptomatic relief. Prolonged or excessive use beyond three consecutive days is not advised due to the risk of rebound congestion (rhinitis medicamentosa). Common side effects may include nasal dryness, irritation, or sneezing. Patients with hypertension, cardiovascular disease, hyperthyroidism, or diabetes should consult a healthcare professional before use. Nozilet should not be used concurrently with monoamine oxidase inhibitors or within 14 days of their discontinuation. Pregnant or breastfeeding women should seek medical advice prior to use. Proper administration technique and adherence to dosing instructions are essential to maximize efficacy and minimize adverse reactions.